Patents by Inventor William E. Pullman

William E. Pullman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of female arousal disorder
    Patent number: 6613768
    Abstract: A method of treating female arousal disorder (FAD) in a female patient is disclosed. The method includes orally administering an agent that inhibits cyclic guanosine 3′5′-monophosphate specific phosphodiesterase type 5 to the female patient.
    Type: Grant
    Filed: October 19, 2001
    Date of Patent: September 2, 2003
    Assignee: Lilly ICOS LLC
    Inventors: Lora L. Allemeier, Diane L. Brashear, Kenneth M. Ferguson, William E. Pullman
  • Articles of manufacture
    Publication number: 20030100478
    Abstract: The present invention relates to highly selective phosphodiesterase (PDE) enzyme inhibitors and to their use in pharmaceutical articles of manufacture. In particular, the present invention relates to potent inhibitors of cyclic guanosine 3′,5′-monophosphate specific phosphodiesterase type 5 (PDE5) that when incorporated into a pharmaceutical product at about 1 to about 20 mg unit dosage are useful for the treatment of sexual dysfunction. The articles of manufacture described herein are characterized by selective PDE5 inhibition, and accordingly, provide a benefit in therapeutic areas where inhibition of PDE5 is desired, with minimization or elimination of adverse side effects resulting from inhibition of other phosphodiesterase enzymes.
    Type: Application
    Filed: July 19, 2002
    Publication date: May 29, 2003
    Applicant: Lilly ICOS LLC
    Inventors: Jeffrey T. Emmick, Kenneth M. Ferguson, William E. Pullman, John S. Whitaker
  • Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor
    Patent number: 6451807
    Abstract: The present invention relates to highly selective phosphodiesterase (PDE) enzyme inhibitors and to their use in methods of treating sexual dysfunction in individuals suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: September 17, 2002
    Assignee: Lilly Icos, LLC.
    Inventors: Jeffrey T. Emmick, Kenneth M. Ferguson, William E. Pullman, John S. Whitaker